1. Home
  2. MGY vs CRSP Comparison

MGY vs CRSP Comparison

Compare MGY & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnolia Oil & Gas Corporation

MGY

Magnolia Oil & Gas Corporation

HOLD

Current Price

$26.71

Market Cap

4.0B

Sector

Energy

ML Signal

HOLD

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$52.81

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGY
CRSP
Founded
2017
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.7B
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
MGY
CRSP
Price
$26.71
$52.81
Analyst Decision
Buy
Buy
Analyst Count
14
19
Target Price
$26.23
$67.78
AVG Volume (30 Days)
3.5M
1.8M
Earning Date
02-05-2026
02-12-2026
Dividend Yield
2.46%
N/A
EPS Growth
N/A
N/A
EPS
1.73
N/A
Revenue
$1,311,845,000.00
$3,510,000.00
Revenue This Year
N/A
$3,246.44
Revenue Next Year
$9.26
$135.19
P/E Ratio
$15.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.09
$30.04
52 Week High
$27.47
$78.48

Technical Indicators

Market Signals
Indicator
MGY
CRSP
Relative Strength Index (RSI) 60.54 50.03
Support Level $25.53 $46.48
Resistance Level $27.47 $50.63
Average True Range (ATR) 0.80 2.65
MACD 0.01 -0.04
Stochastic Oscillator 57.10 58.89

Price Performance

Historical Comparison
MGY
CRSP

About MGY Magnolia Oil & Gas Corporation

Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: